Nitorum Capital, L.P. Bio Rad Laboratories, Inc. Transaction History

Nitorum Capital, L.P.

$941 Million
Q1 2024

A detailed history of Nitorum Capital, L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Nitorum Capital, L.P. holds 111,653 shares of BIO stock, worth $30.5 Million. This represents 4.11% of its overall portfolio holdings.

Number of Shares

111,653

Previous 134,904 17.24%

Holding current value

$30.5 Million

Previous $43.6 Million 11.35%

% of portfolio

4.11%

Previous 4.81%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $7.07 Million - $8.18 Million	-23,251 Reduced 17.24%	111,653 $38.6 Million
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $4.72 Million - $6.4 Million	-17,529 Reduced 11.5%	134,904 $43.6 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $10.3 Million - $12.4 Million	-29,420 Reduced 16.18%	152,433 $54.6 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $9.93 Million - $13.4 Million	27,617 Added 17.91%	181,853 $68.9 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $27.6 Million - $33.2 Million	-66,021 Reduced 29.97%	154,236 $73.9 Million

Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $5.21 Million - $6.75 Million	14,800 Added 7.2%	220,257 $92.6 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $7.01 Million - $9.58 Million	17,000 Added 9.02%	205,457 $85.7 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $36.1 Million - $46.5 Million	77,900 Added 70.46%	188,457 $93.3 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $58 Million - $81.3 Million	110,557 New	110,557 $62.3 Million

Others Institutions Holding BIO

# of Institutions

489

Shares Held

17.8M

Call Options Held

44.9K

Put Options Held

79.7K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.73B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nitorum Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Nitorum Capital, L.P. with notifications on news.

Account

Nitorum Capital, L.P. Bio Rad Laboratories, Inc. Transaction History